{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:38:12Z","timestamp":1779100692715,"version":"3.51.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"DOI":"10.2146\/ajhp110049","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T17:54:28Z","timestamp":1323971668000},"page":"35-39","source":"Crossref","is-referenced-by-count":69,"title":["Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy"],"prefix":"10.1093","volume":"69","author":[{"given":"Christie M.","family":"Mock","sequence":"first","affiliation":[{"name":"Wishard Health Services, Indianapolis, IN; at the time of writing she was Postgraduate Year 1 Pharmacy Resident, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen H.","family":"Schwetschenau","sequence":"additional","affiliation":[{"name":"Cincinnati Veterans Affairs Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041606594291100_b1-0690035","unstructured":"Lexi-Drugs Online. Valproic acid. www.crlonline.com\/crlonline (accessed 2009 Sep 21)."},{"key":"2019041606594291100_b2-0690035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab Brain Dis."},{"key":"2019041606594291100_b3-0690035","unstructured":"POISINDEX Management. Valproic acid. www.thomsonhc.com (accessed 2009 Sep 21)."},{"key":"2019041606594291100_b4-0690035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol."},{"key":"2019041606594291100_b5-0690035","unstructured":"Burns\n              MJ\n            \n            \n              Palmer\n              BF\n            \n          . Valproic acid poisoning. http:\/\/uptodateonline.com (accessed 2009 Sep 21)."},{"key":"2019041606594291100_b6-0690035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity\u2014what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit Care."},{"key":"2019041606594291100_b7-0690035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jat\/20.1.55","article-title":"Valproic acid overdose and l-carnitine therapy","volume":"20","author":"Ishikura","year":"1996","journal-title":"J Anal Toxicol."},{"key":"2019041606594291100_b8-0690035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic acid therapy","volume":"101","author":"Ohtani","year":"1982","journal-title":"J Pediatr."},{"key":"2019041606594291100_b9-0690035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0887-8994(97)00026-X","article-title":"Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine","volume":"16","author":"Gidal","year":"1997","journal-title":"Pediatr Neurol."},{"key":"2019041606594291100_b10-0690035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1345\/aph.1E063","article-title":"Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman","volume":"38","author":"Mallet","year":"2004","journal-title":"Ann Pharmacother."},{"key":"2019041606594291100_b11-0690035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198734010-00001","article-title":"L-carnitine: a preliminary review of its pharmacokinetics, and its therapeutic use in ischemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism","volume":"34","author":"Goa","year":"1987","journal-title":"Drugs."},{"key":"2019041606594291100_b12-0690035","volume-title":"Carnitor (levocarnitine) package insert","year":"2004"},{"key":"2019041606594291100_b13-0690035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.410060319","article-title":"Treatment of accidental sodium valproate overdose with an opiate antagonist","volume":"6","author":"Steiman","year":"1979","journal-title":"Ann Neurol."},{"key":"2019041606594291100_b14-0690035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0196-0644(89)80220-3","article-title":"Central nervous system manifestations of a valproic acid overdose responsive to naloxone","volume":"18","author":"Alberto","year":"1989","journal-title":"Ann Emerg Med."},{"key":"2019041606594291100_b15-0690035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0196-0644(99)70381-1","article-title":"Naloxone in the reversal of coma induced by sodium valproate","volume":"33","author":"Montero","year":"1999","journal-title":"Ann Emerg Med."},{"key":"2019041606594291100_b16-0690035","first-page":"178","article-title":"An unusual presentation of opioid-like syndrome in pediatric valproic acid poisoning","volume":"43","author":"Espinoza","year":"2001","journal-title":"Vet Hum Toxicol."},{"key":"2019041606594291100_b17-0690035","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1345\/aph.1P135","article-title":"L-carnitine for acute valproic acid overdose: a systematic review of published cases","volume":"44","author":"Perrott","year":"2010","journal-title":"Ann Pharmcother."},{"key":"2019041606594291100_b18-0690035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann Pharmacother."},{"key":"2019041606594291100_b19-0690035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajem.2005.02.015","article-title":"L-carnitine was safely administered in the setting of valproate toxicity","volume":"23","author":"LoVecchio","year":"2005","journal-title":"Am J Emerg Med."},{"key":"2019041606594291100_b20-0690035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1553-2712.2001.tb01102.x","article-title":"Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy","volume":"8","author":"Barrueto","year":"2001","journal-title":"Acad Emerg Med."},{"key":"2019041606594291100_b21-0690035","first-page":"8","article-title":"Carnitine for valproic acid-induced hyperammonemia","volume":"154","author":"Raby","year":"1997","journal-title":"Am J Psychiatry."},{"key":"2019041606594291100_b22-0690035","first-page":"219","article-title":"Severe hyperammonemic encephalopathy shortly after valproic acid prescription and rapid awakening following levocarnitine","volume":"38","author":"Borbath","year":"2000","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606594291100_b23-0690035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.psy.49.1.82","article-title":"Severe acute hyperammonemia after brief exposure to valproate","volume":"49","author":"Eubanks","year":"2008","journal-title":"Psychosomatics."},{"key":"2019041606594291100_b24-0690035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00330-004-2338-9","article-title":"Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma","volume":"15","author":"Hantson","year":"2005","journal-title":"Eur Radiol."},{"key":"2019041606594291100_b25-0690035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MOP.0b013e32805e879a","article-title":"Carnitine as an antidote for acute valproate toxicity in children","volume":"19","author":"Russell","year":"2007","journal-title":"Curr Opin Pediatr."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/1\/35\/28455020\/ajhp0035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T07:00:31Z","timestamp":1555398031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/1\/35\/5111837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110049","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,1,1]]},"published":{"date-parts":[[2012,1,1]]}}}